Federated Investors Inc. PA raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 323.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 79,608 shares of the company’s stock after buying an additional 60,824 shares during the period. Federated Investors Inc. PA owned 0.10% of Henry Schein worth $14,569,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its position in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the period. MARSHALL WACE ASIA Ltd purchased a new position in Henry Schein during the first quarter valued at $50,281,000. Marshall Wace North America L.P. purchased a new position in Henry Schein during the first quarter valued at $50,281,000. PGGM Investments purchased a new position in Henry Schein during the second quarter valued at $32,623,000. Finally, JPMorgan Chase & Co. boosted its position in Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock valued at $257,650,000 after buying an additional 167,213 shares during the period. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Shares of Henry Schein, Inc. (HSIC) opened at 171.57 on Friday. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The company’s 50-day moving average is $177.99 and its 200-day moving average is $175.84. The company has a market cap of $13.56 billion, a price-to-earnings ratio of 25.07 and a beta of 1.09. Shares of Henry Schein are set to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly minted shares will be distributed to shareholders after the market closes on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter last year, the firm posted $1.64 EPS. The business’s revenue was up 6.4% on a year-over-year basis. Equities research analysts predict that Henry Schein, Inc. will post $7.27 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Federated Investors Inc. PA Has $14.57 Million Position in Henry Schein, Inc. (HSIC)” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://theolympiareport.com/2017/08/27/federated-investors-inc-pa-has-14-57-million-position-in-henry-schein-inc-hsic.html.

HSIC has been the topic of several analyst reports. Stifel Nicolaus boosted their price target on shares of Henry Schein from $174.00 to $178.00 and gave the stock a “hold” rating in a report on Wednesday, May 10th. Barrington Research boosted their price target on shares of Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a report on Wednesday, May 10th. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, May 24th. Piper Jaffray Companies started coverage on shares of Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 target price on the stock. Finally, Credit Suisse Group reiterated a “hold” rating and issued a $160.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.